BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37921873)

  • 1. Clonally related transformation from Waldenström macroglobulinemia to diffuse large B-cell lymphoma with central nervous system involvement at diagnosis: a case report and literature review.
    Chen H; Zhao D; Wang Z; Zhang W; Wang W
    Clin Exp Med; 2023 Dec; 23(8):5473-5476. PubMed ID: 37921873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diffuse large B-cell lymphoma occurring in a Waldenström macroglobulinemia patient with central nervous system infiltration].
    Hayashi Y; Sata H; Akuta K; Toda J; Kusakabe S; Ueda T; Ueda Y; Fujita J; Tadokoro S; Maeda T; Nishimura J; Shibayama H; Oritani K; Kanakura Y
    Rinsho Ketsueki; 2015 Nov; 56(11):2351-6. PubMed ID: 26666724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Kobayashi H; Asada N; Egusa Y; Ikeda T; Sakamoto M; Abe M; Ennishi D; Sakata M; Takaki A; Kawahara S; Meguri Y; Nishimori H; Fujii N; Matsuoka KI; Sato Y; Yoshino T; Maeda Y
    Int J Hematol; 2021 Sep; 114(3):401-407. PubMed ID: 33907976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).
    Durot E; Tomowiak C; Michallet AS; Dupuis J; Hivert B; Leprêtre S; Toussaint E; Godet S; Merabet F; Van Den Neste E; Ivanoff S; Roussel X; Zini JM; Regny C; Lemal R; Sutton L; Perrot A; Le Dû K; Kanagaratnam L; Morel P; Leblond V; Delmer A
    Br J Haematol; 2017 Nov; 179(3):439-448. PubMed ID: 28770576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases.
    Lin P; Mansoor A; Bueso-Ramos C; Hao S; Lai R; Medeiros LJ
    Am J Clin Pathol; 2003 Aug; 120(2):246-53. PubMed ID: 12931555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemia.
    Castillo JJ; Gustine J; Meid K; Dubeau T; Hunter ZR; Treon SP
    Am J Hematol; 2016 Oct; 91(10):1032-5. PubMed ID: 27415417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Treatment of Bing-Neel Syndrome Accompanying Waldenström's Macroglobulinemia with R-MPV: A Case Report.
    Kikukawa Y; Yamamura-Fujimoto A; Endo S; Miyagawa E; Kawano Y; Ueno S; Mitsuya H; Hata H; Okuno Y
    J Clin Exp Hematop; 2015; 55(2):113-9. PubMed ID: 26490525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88
    Kida T; Tanimura A; Ono A; Matsui T; Honma K; Fujita J; Maeda T; Shibayama H; Oritani K; Morii E; Kanakura Y
    Rinsho Ketsueki; 2017; 58(2):155-160. PubMed ID: 28321094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of histological transformation events in Waldenström's macroglobulinemia (WM) and related disorders.
    Owen RG; Bynoe AG; Varghese A; de Tute RM; Rawstron AC
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):176-9. PubMed ID: 21856554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma.
    Berendsen MR; van Bladel DAG; Hesius E; Berganza Irusquieta C; Rijntjes J; van Spriel AB; van der Spek E; Pruijt JFM; Kroeze LI; Hebeda KM; Croockewit S; Stevens WBC; van Krieken JHJM; Groenen PJTA; van den Brand M; Scheijen B
    Hemasphere; 2023 Nov; 7(11):e976. PubMed ID: 37928625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bing-Neel syndrome: A case reports.
    Demircioğlu S; Oltulu P; Emlik GD; Tekinalp A; Çeneli Ö
    J Oncol Pharm Pract; 2021 Oct; 27(7):1758-1761. PubMed ID: 33356992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia.
    Talaulikar D; Tomowiak C; Toussaint E; Morel P; Kapoor P; Castillo JJ; Delmer A; Durot E
    Hematol Oncol Clin North Am; 2023 Aug; 37(4):787-799. PubMed ID: 37246087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waldenstrom macroglobulinemia and simultaneous intravascular large B-cell lymphoma: Rare transformation or unhappy coincidence?
    Kline KAF; Lee ST; Law JY; Kallen M
    Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e788-e791. PubMed ID: 35525836
    [No Abstract]   [Full Text] [Related]  

  • 14. Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
    Jafri H; Khan I; Sidda A; Khan NAJ; Kheetan M; Griswold D; Pacioles T
    J Investig Med High Impact Case Rep; 2021; 9():23247096211021228. PubMed ID: 34078157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib.
    Yang G; Buhrlage SJ; Tan L; Liu X; Chen J; Xu L; Tsakmaklis N; Chen JG; Patterson CJ; Brown JR; Castillo JJ; Zhang W; Zhang X; Liu S; Cohen P; Hunter ZR; Gray N; Treon SP
    Blood; 2016 Jun; 127(25):3237-52. PubMed ID: 27143257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of diffuse large B-cell lymphoma in a patient with Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma: clonal identity between two B-cell neoplasms.
    Shiseki M; Masuda A; Watanabe N; Fujii M; Kimura T; Yoshinaga K; Mori N; Teramura M; Motoji T
    Hematol Rep; 2011 Aug; 3(2):e10. PubMed ID: 22184531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder.
    Nie G; Sun L; Zhang C; Yuan Y; Mao H; Wang Z; Li J; Duan S; Xing C; Zhang B
    Front Immunol; 2022; 13():903315. PubMed ID: 36172352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous presentation of Waldenström macroglobulinemia and multiple myeloma: multidisciplinary diagnosis, treatment and 30-month follow-up.
    Carulli G; Ciancia EM; Azzarà A; Ottaviano V; Grassi S; Ciabatti E; Ferreri MI; Rocco M; Marini A; Petrini M
    J Clin Exp Hematop; 2013; 53(1):29-36. PubMed ID: 23801131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clonal-related transformation from Waldenström macroglobulinemia to diffuse large B cell lymphoma during the treatment of ibrutinib: a case report and literature review].
    Xia Y; Zhu HY; Wang L; Chen RZ; Chen W; Ding CY; Xu W; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2020 Sep; 41(9):770-772. PubMed ID: 33113611
    [No Abstract]   [Full Text] [Related]  

  • 20. Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients.
    Lin P; Bueso-Ramos C; Wilson CS; Mansoor A; Medeiros LJ
    Am J Surg Pathol; 2003 Aug; 27(8):1104-13. PubMed ID: 12883242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.